29 funds hold it.Insiders net selling.
Net selling: insiders sold $3.4M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 22, 2026
Financial period
Third quarter 2026
Earnings per share
$1.02 expected
Revenue
$1.46B expected
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 22, 2026 | $1.04est. $1.02 | +2.32%beat | $1.48Best. $1.46B+1.25% | -25.2%from $1.98B |
| Jun 30, 2026Reported Jul 23, 2026 | $0.89Company GAAP | Not comparableDifferent EPS measure | $1.50BCompany release | -28.6%from $2.10B |
| Mar 31, 2026Reported Apr 23, 2026 | $0.96est. $0.93 | +2.84%beat | $2.14BSEC filing | +2.0%from $2.10B |
| Dec 31, 2025Reported Jan 29, 2026 | $0.96est. $0.92 | +4.83%beat | $2.08BAlpha Vantage | +2.5%from $2.03B |
| Sep 30, 2025Reported Oct 21, 2025 | $0.88est. $0.85 | +3.53%beat | $1.98BSEC filing | +4.0%from $1.90B |
| Jun 30, 2025Reported Jul 24, 2025 | $0.85est. $0.81 | +4.94%beat | $2.10BSEC filing | +17.2%from $1.79B |
| Mar 31, 2025Reported Apr 24, 2025 | $0.79est. $0.77 | +2.60%beat | $2.10BSEC filing | +25.2%from $1.67B |
| Dec 31, 2024Reported Jan 29, 2025 | $0.76est. $0.75 | +1.33%beat | $2.03BAlpha Vantage | +23.3%from $1.65B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.08B | $2.14B | $2.53B | $2.39B |
| Cost of what it sold | $688.0M | $730.0M | $1.03B | $912.0M |
| Gross profit | $1.39B | $1.41B | $1.50B | $1.48B |
| What it spent | ||||
| Sales and admin | $179.0M | $541.0M | $488.0M | $561.0M |
| Other operating costs | $583.0M | $209.0M | $134.0M | $188.0M |
| Total operating expenses | $762.0M | $750.0M | $622.0M | $749.0M |
| What was left | ||||
| Operating profit | $630.0M | $657.0M | $877.0M | $732.0M |
| Interest on debt | $88.0M | $87.0M | $86.0M | $86.0M |
| Profit before tax | $580.0M | $677.0M | $653.0M | $701.0M |
| Tax | $61.0M | $158.0M | $146.0M | $162.0M |
| Net profit | $519.0M | $519.0M | $507.0M | $540.0M |
| EBITDA | $822.0M | $721.0M | $878.0M | $952.0M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Korean brokerages to offer near-24-hour US stock trading from Dec. 6
Leans bullishNov 8ADERFXX Stock Price and Chart — NASDAQ:ADERFXX
NeutralNov 7QQQ Vs. TQQQ: The 3X Nasdaq ETF’s Compounding Trap Is Costing Investors Big - Invesco QQQ Trust, Series 1
NeutralNov 7Nasdaq achieves a 1% advance; indexes see big losses for the week
Leans bullishNov 7Nasdaq Inc (CEUX:NAQd) Stock Price, Trades & News
NeutralNov 7Nasdaq's Tal Cohen Sells 2,286 Shares at $109.4 Each on November 4, 2026
NeutralNov 7After meeting a $1 share-price rule, POMDOCTOR shares will keep trading on Nasdaq.
Leans bullishNov 6Datavault AI Overhauls Leadership as Restatement Fallout Continues; Shares Jump 16%
Leans bullishNov 6